NY State Senate Bill 2025-S6413

Senate Bill S6413

2025-2026 Legislative Session

Relates to establishing a state amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND) registry

download bill text pdf

Current Bill Status - In Senate Committee Finance Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
May 28, 2025	reported and committed to finance
Mar 13, 2025	referred to health

co-Sponsors

2025-S6413 (ACTIVE) - Details

See Assembly Version of this Bill:: A7845
Current Committee:: Senate Finance
Law Section:: Public Health Law
Laws Affected:: Add Art 20-C §§2020 - 2024, Pub Health L

2025-S6413 (ACTIVE) - Summary

Requires the department of health to establish a registry for the collection of information on the incidence and prevalence of amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND) in the state; requires that every physician, nurse practitioner, physician assistant and general hospital that diagnoses or treats a patient diagnosed with ALS or MND give notice to the department of cases of ALS or MND coming under their care; requires that patients diagnosed with ALS or MND be provided with written and verbal notice regarding the collection of information and patient data on ALS and MND and provides a method for patients to opt out of the collection of data; provides for duties of the department and the commissioner of health in relation thereto.

2025-S6413 (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S6413

SPONSOR: SCARCELLA-SPANTON
 
TITLE OF BILL:

An act to amend the public health law, in relation to establishing a
state amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND)
registry

 
PURPOSE OR GENERAL IDEA OF BILL:

To ensure the collection of accurate, reliable data in order to enhance
delivery of state services to individuals with ALS, identify high-risk
groups, support patient contact studies, serve as a valuable data
resource to prevent and optimally manage ALS and MND, assist in deter-
mining incidence and prevalence of ALS and MND more accurately, help
researchers study patterns of ALS over time, and ultimately help
researchers identify a cure for ALS.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 of the bill provides definitions, establishes a duty to report

cases of ALS/MND for healthcare practitioners, provides for the informed
consent of patients and enables patients to opt-out of the registry,
provides for the creation of a ALS and MN Disease registry and estab-
lishes which experts the department may consult with for the development
and implementation of this registry, provides data storing, reporting,
and sharing requirements for the department of health, and authorizes
the Commissioner of Health to make regulations to implement these
provisions.

Section 2 of the bill provides an effective date.

 
JUSTIFICATION:

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative
disease that affects nerve cells in the brain and spinal cord. Over
time, it leads to gradual loss of muscle control, resulting in paralysis
and respiratory failure, as it impacts the neurons responsible for
voluntary movement. There is no cure for ALS, and the disease is always
fatal. The average life expectancy after diagnosis is between two to
five years, though some individuals live longer.  ALS affects speech,
swallowing, movement, and breathing, but cognitive function is often
preserved.

At any given time, approximately 30,000 people in the United States are
living with ALS, with around 5,000 to 6,000 new cases diagnosed each
year. The estimated lifetime risk of developing the disease is about one
in three hundred. While ALS is more common in people over the age of
fifty-five, it can occur at any age. Most cases, about 90 percent, occur
sporadically with no known family history, while the remaining 10
percent are inherited through genetic mutations.

Currently, ALS case reporting in the United States is voluntary, relying
on self-enrollment in the National ALS Registry managed by the CDC.
While this Registry is a valuable tool for tracking ALS cases, its self-
reporting nature creates a major data gap-many people with ALS are never
registered, leaving researchers and policymakers with an incomplete
picture of the disease. An ALS registry will enable New York State to
conduct true population-based studies in ALS. The size of New York would
make it on par with the Netherlands registry, and far larger than the
ones in Ireland, Italy, and the UK. Pairing this with environmental and
lifestyle questionnaires would enable the identification of possible
disease-modifying interventions that are truly scalable. The scientific
value of such population studies is enormous and would easily dwarf the
environmental and epidemiological studies being done elsewhere.

 
PRIOR LEGISLATIVE HISTORY:

This is a new bill.

 
FISCAL IMPLICATIONS:

To be determined

 
EFFECTIVE DATE:
This act shall take effect on the 90th day after it shall have become
law.

2025-S6413 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6413
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                              March 13, 2025
                                ___________
 
 Introduced  by Sen. SCARCELLA-SPANTON -- read twice and ordered printed,
   and when printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in  relation  to  establishing  a
   state  amyotrophic  lateral  sclerosis  (ALS) and motor neuron disease
   (MND) registry

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  The  public health law is amended by adding a new article
 20-C to read as follows:
 
                               ARTICLE 20-C
       STATE AMYOTROPHIC LATERAL SCLEROSIS AND MOTOR NEURON DISEASE
                                 REGISTRY
 
 SECTION 2020. DEFINITIONS.
         2021. DUTY TO REPORT.
         2022. ESTABLISHMENT OF REGISTRY.
         2023. DUTIES OF THE DEPARTMENT.
         2024. DUTIES OF THE COMMISSIONER.
   § 2020. DEFINITIONS. AS USED IN  THIS  ARTICLE,  THE  FOLLOWING  TERMS
 SHALL HAVE THE FOLLOWING MEANINGS:
   1.  "ALS" MEANS AMYOTROPHIC LATERAL SCLEROSIS, A NEUROLOGICAL DISORDER
 THAT AFFECTS MOTOR NEURONS, THE NERVE CELLS IN THE BRAIN AND SPINAL CORD
 THAT CONTROL VOLUNTARY MUSCLE MOVEMENT AND BREATHING.
   2. "MND" MEANS MOTOR NEURON DISEASE, A GROUP OF PROGRESSIVE NEUROLOGI-
 CAL DISORDERS THAT DESTROY MOTOR NEURONS, THE CELLS THAT CONTROL  SKELE-
 TAL  MUSCLE  ACTIVITY SUCH AS WALKING, BREATHING, SPEAKING, AND SWALLOW-
 ING.    THIS  GROUP  INCLUDES  DISEASES  SUCH  AS  AMYOTROPHIC   LATERAL
 SCLEROSIS, PROGRESSIVE BULBAR PALSY, PRIMARY LATERAL SCLEROSIS, PROGRES-
 SIVE  MUSCULAR  ATROPHY, SPINAL MUSCULAR ATROPHY, KENNEDY'S DISEASE, AND
 POST-POLIO SYNDROME.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10901-01-5

 S. 6413                             2
 
   § 2021. DUTY TO REPORT. 1. EVERY PHYSICIAN, NURSE PRACTITIONER, PHYSI-
 CIAN ASSISTANT AND GENERAL HOSPITAL THAT  DIAGNOSES  OR  IS  TREATING  A
 PATIENT  DIAGNOSED  WITH  ALS OR MND SHALL GIVE NOTICE NO LATER THAN ONE
 HUNDRED EIGHTY DAYS OF EACH CASE OF ALS OR MND COMING UNDER THEIR  CARE,
 TO  THE  DEPARTMENT,  IN  A FORMAT TO BE DETERMINED BY THE COMMISSIONER,
 EXCEPT AS OTHERWISE PROVIDED IN THIS ARTICLE.
   2. ALL PATIENTS DIAGNOSED WITH ALS OR MND SHALL BE PROVIDED WITH WRIT-
 TEN AND VERBAL  NOTICE  REGARDING  THE  COLLECTION  OF  INFORMATION  AND
 PATIENT  DATA ON ALS AND MND. PATIENTS WHO DO NOT WISH TO PARTICIPATE IN
 THE COLLECTION OF DATA SHALL AFFIRMATIVELY  OPT  OUT  IN  WRITING  AFTER
 AMPLE  OPPORTUNITY  TO  REVIEW SUCH NOTICE, PROVIDED THAT THE MERE INCI-
 DENCE OF A PATIENT WITH ALS OR MND SHALL BE THE SOLE  REQUIRED  INFORMA-
 TION  FOR  THE  REGISTRY  UNDER  SECTION TWO THOUSAND TWENTY-TWO OF THIS
 ARTICLE FOR ANY PATIENT WHO CHOOSES NOT TO PARTICIPATE.
   § 2022. ESTABLISHMENT OF REGISTRY. 1. THE DEPARTMENT  SHALL  ESTABLISH
 AN  ALS  AND MND REGISTRY FOR THE COLLECTION OF INFORMATION ON THE INCI-
 DENCE AND PREVALENCE OF ALS AND MND. THE DEPARTMENT MAY CONSULT WITH ALS
 AND MND EXPERTS, INCLUDING NEUROLOGISTS, PATIENTS LIVING  WITH  ALS  AND
 MND, AND ALS AND MND RESEARCHERS TO ASSIST IN THE DEVELOPMENT AND IMPLE-
 MENTATION  OF  SUCH  REGISTRY,  AND  TO  DETERMINE  WHAT  DATA  SHALL BE
 COLLECTED.
   2. ALL INFORMATION MAINTAINED BY THE DEPARTMENT UNDER  THE  PROVISIONS
 OF  THIS  SECTION SHALL BE CONFIDENTIAL EXCEPT AS NECESSARY TO CARRY OUT
 THE PROVISIONS OF THIS SECTION AND SHALL NOT BE RELEASED FOR  ANY  OTHER
 PURPOSE.
   3.  THE  DEPARTMENT  MAY  ENTER  INTO  AN  AGREEMENT  TO  PROVIDE DATA
 COLLECTED IN THE ALS AND MND REGISTRY TO THE FEDERAL CENTERS FOR DISEASE
 CONTROL AND PREVENTION, OR SUCCESSOR AGENCY, TO LOCAL  HEALTH  OFFICERS,
 OR HEALTH RESEARCHERS FOR THE STUDY OF ALS AND MND FOR PUBLIC HEALTH AND
 RESEARCH  PURPOSES.  DATA  SHALL  BE  PROVIDED  IN SUMMARY, STATISTICAL,
 AGGREGATE, OR OTHER FORM SUCH THAT NO INDIVIDUAL PERSON CAN  BE  IDENTI-
 FIED.
   4.  ON OR BEFORE JANUARY FIRST, TWO THOUSAND TWENTY-SEVEN, THE DEPART-
 MENT SHALL CREATE AND MAINTAIN A PUBLIC WEBSITE  CALLED  THE  "NEW  YORK
 STATE  ALS  AND  MN DISEASE REGISTRY" WHICH SHALL INCLUDE INFORMATION ON
 THE INCIDENCE AND PREVALENCE OF ALS AND MND IN THE STATE BY COUNTY,  AND
 DEMOGRAPHIC INFORMATION ON AFFECTED PATIENTS.
   §  2023.  DUTIES  OF  THE  DEPARTMENT. 1. ALS AND MND REPORTS AND DATA
 SHALL BE MAINTAINED BY THE DEPARTMENT IN A MANNER SUITABLE FOR  RESEARCH
 PURPOSES  AND  SHALL BE MADE AVAILABLE TO PEOPLE AS SET FORTH IN SECTION
 TWO THOUSAND TWENTY-TWO OF THIS ARTICLE.
   2. ALL INFORMATION COLLECTION UNDER THIS ARTICLE SHALL BE CONFIDENTIAL
 INSOFAR AS THE IDENTITY OF INDIVIDUAL PATIENTS IS CONCERNED AND SHALL BE
 USED SOLELY FOR THE PURPOSES AS PROVIDED IN THIS ARTICLE. ACCESS TO SUCH
 INFORMATION SHALL BE LIMITED TO AUTHORIZED EMPLOYEES OF  THE  DEPARTMENT
 AS  WELL AS PERSONS AND ORGANIZATIONS IDENTIFIED IN SECTION TWO THOUSAND
 TWENTY-TWO OF THIS ARTICLE WITH VALID SCIENTIFIC INTEREST AND QUALIFICA-
 TIONS, AS DETERMINED BY THE COMMISSIONER, WHO ARE ENGAGED IN  DEMOGRAPH-
 IC, EPIDEMIOLOGICAL, OR OTHER SIMILAR STUDIES RELATED TO PUBLIC HEALTH.
   3.  THE DEPARTMENT SHALL MAINTAIN AN ACCURATE RECORD OF ALL PEOPLE WHO
 ARE GIVEN ACCESS TO THE INFORMATION CONTAINED IN THE ALS AND MND  REGIS-
 TRY.  SUCH  A  RECORD  SHALL  INCLUDE THE NAME OF THE PERSON AUTHORIZING
 ACCESS, THE NAME, TITLE AND ORGANIZATIONAL AFFILIATION OF PERSONS  GIVEN
 ACCESS, DATES OF ACCESS, AND THE SPECIFIC PURPOSES FOR WHICH INFORMATION
 IS TO BE USED.
 S. 6413                             3
 
   4.  ANY  PERSON  WHO,  IN VIOLATION OF A WRITTEN AGREEMENT TO MAINTAIN
 CONFIDENTIALITY, DISCLOSES ANY INFORMATION PROVIDED UNDER THIS  ARTICLE,
 OR  WHO  USES  INFORMATION PROVIDED UNDER THIS ARTICLE IN A MANNER OTHER
 THAN THAT PRESCRIBED BY THE COMMISSIONER, MAY BE DENIED  FURTHER  ACCESS
 TO ANY CONFIDENTIAL INFORMATION MAINTAINED BY THE DEPARTMENT.
   §  2024.  DUTIES  OF THE COMMISSIONER. THE COMMISSIONER MAY PROMULGATE
 ANY REGULATIONS NECESSARY TO IMPLEMENT THE PROVISIONS OF  THIS  ARTICLE,
 INCLUDING BUT NOT LIMITED TO:
   1. ESTABLISHING THE FORM, CONTENT, AND MANNER BY WHICH PROVIDERS SHALL
 REPORT  ALS  AND  MND  INFORMATION  INTO  THE REGISTRY ESTABLISHED UNDER
 SECTION TWO THOUSAND TWENTY-TWO OF THIS ARTICLE;
   2. PRESCRIBING THE PERMISSIBLE USES FOR THE INFORMATION MADE AVAILABLE
 UNDER THIS ARTICLE; AND
   3. ESTABLISHING PROCEDURES TO MAINTAIN CONFIDENTIALITY OF  INFORMATION
 COLLECTED  BY PROVIDERS AND PROVIDED TO MEMBERS OF THE DEPARTMENT PURSU-
 ANT TO THIS ARTICLE. THIS SHALL  INCLUDE  A  PROCEDURE  TO  ENSURE  THAT
 CONFIDENTIAL PATIENT INFORMATION IS DEIDENTIFIED PRIOR TO BEING PROVIDED
 TO AUTHORIZED PARTICIPANTS UNDER THIS ARTICLE.
   §  2.  This  act shall take effect on the ninetieth day after it shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal of any rule or regulation necessary  for  the  implementation  of
 this  act  on its effective date are authorized to be made and completed
 on or before such effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S6413

Share this bill

Sponsored By

Jessica Scarcella-Spanton